Rare diseases
Investigational molecules
Locations
Back to Germany31 clinical trials in Elsterwerda, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
GermanyStudy of Once‑Weekly Eloralintide (LY3841136 Sodium) in Adults with Obesity or Overweight, Type 2 Diabetes, and High Cardiovascular Risk
GermanyA study testing cagrilintide and semaglutide for heart safety in people with cardiovascular disease
GermanyA Study of Cagrilintide and Semaglutide for Weight Loss in People with Type 2 Diabetes and Overweight or Obesity
GermanyA study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation
GermanyStudy of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease
GermanyEvaluation of Ziltivekimab in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction and Systemic Inflammation
GermanyStudy on the Effect of Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease Not Adequately Managed by Current Lipid-Lowering Treatments
GermanyStudy on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation
GermanyEvaluation of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Type 2 Diabetes Patients with High Cardiovascular Risk
GermanyA study comparing cagrilintide and semaglutide combination to semaglutide, cagrilintide, and placebo in adults with type 2 diabetes on metformin
GermanyA study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation
GermanyThe busiest research cities in the country
What the registry says about research in the country
Clinical investigations focusing on weight management and Type 2 Diabetes treatments, evaluating innovative therapies for improved metabolic outcomes.
Studies combining lifestyle modifications with novel therapeutic approaches for comprehensive metabolic health improvement.
Research targeting atherosclerotic cardiovascular disease and innovative treatments for various forms of heart failure.
Comprehensive evaluation of new therapeutic agents for both preserved and reduced ejection fraction heart failure.
Advanced clinical research examining treatments for resistant hypertension and atrial fibrillation, focusing on innovative therapeutic approaches.
Evaluating next-generation medications for better control of complex cardiovascular conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
